Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Intrexon (XON) +4.8% AH after David Einhorn's Greenlight

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dav1234 Member Profile
 
Followed By 121
Posts 93,348
Boards Moderated 4
Alias Born 10/29/07
160x600 placeholder
U.S. Stocks Rally; Dow Up Triple-digits
The U.S. stock market surged in morning trade, sending the S&P 500 and Dow Jones Industrial Average into record territory, after a surprise fresh stimulus from the Bank of Japan.
Top Equities Stories Of The Day
Sony Posts Hefty Loss
U.S. Stocks, Bonds Dip on Fed Outlook
Starbucks Sales Growth Disappoints; Delivery Is Coming -- 3rdUpdate
Omega Healthcare to Buy Aviv REIT
Twitter Demotes Product Chief Daniel Graf
InTrade Founders Launch New Forum for Political Predictions
Jefferies Expected to Book up to $15 Million Loss on Toms Shoes Debt, Sources Say -- Update
Exxon Mobil Looks for More Barrels, More Profit -- Earnings Preview
dav1234   Thursday, 11/14/13 06:09:02 PM
Re: None
Post # of 183400 
Intrexon (XON) +4.8% AH after David Einhorn's Greenlight Capital reveals it opened a ~2.1M-share position in the biotech company that went public in August

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist